Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration

Neurology

Volumn 66, Issue 1, 2006, Pages 146-147

  Galimberti, D ^a   Schoonenboom, N ^b,c   Scheltens, P ^b   Fenoglio, C ^a   Venturelli, E ^a   Pijnenburg, Y A L ^b   Bresolin, N ^a   Scarpini, E ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; TAU PROTEIN; 5(4' HYDROXYBENZYLIDENOIMINO) 3 METHYLISOTHIAZOLO(5,4 D)PYRIMIDINE (7H) 4,6 DIONE; 5(4'-HYDROXYBENZYLIDENOIMINO)-3-METHYLISOTHIAZOLO(5,4-D)PYRIMIDINE-(7H)-4,6-DIONE; BIOLOGICAL MARKER; CCL2 PROTEIN, HUMAN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PYRIMIDINONE DERIVATIVE; THIAZOLE DERIVATIVE;

ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; CELL DEATH; FRONTOTEMPORAL DEMENTIA; HIGH RISK PATIENT; HUMAN; IMMUNOREACTIVITY; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; AGED; CEREBROSPINAL FLUID; COGNITIVE DEFECT; DEMENTIA; DISEASE COURSE; FEMALE; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; NERVE CELL; ONSET AGE; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PUNCTURE; SEX DIFFERENCE; UPREGULATION;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CELL DEATH; CEREBROSPINAL FLUID; CHEMOKINE CCL2; CHEMOKINES; COGNITION DISORDERS; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; NERVE DEGENERATION; NEURONS; PREDICTIVE VALUE OF TESTS; PYRIMIDINONES; SEX FACTORS; SPINAL PUNCTURE; THIAZOLES; UP-REGULATION;

EID: 33645730212     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000191324.08289.9d     Document Type: Article

References (7)

1. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383-421.
2. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
3. Xia MQ, Hyman BT. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J Neurovirol 1999;5:32-41.
4. Infante J, Sanz C, Fernández-Luna JL, Llorca J, Berciano J, Combarros O. Gene-gene interaction between interleukin-1A and interleukin-8 increases Alzheimer's disease risk. J Neurol 2004;251:482-483.
5. Galimberti D, Schoonenboom N, Scarpini E, Scheltens P, on behalf of the Dutch-Italian Alzheimer Research Group. Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients. Ann Neurol 2003;53:547-548.
6. Kalehua AN, Nagel JE, Whelchel LM, et al. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration. Exp Cell Res 2004;297:197-211.
7. Araujo DM, Cotman CW. Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res 1993;600:49-55.